XOMA Corp (16)

Browse by Contract Category

Contracts

Underwriting Agreement, dated as of December 10, 2020, by and between the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein (Filed With SEC on December 11, 2020)
Amendment to Amended and Restated Research, Development and Commercialization Agreement, between the Company and Novartis Vaccine and Diagnostics, Inc., dated September 30, 2015... (Filed With SEC on November 5, 2020)
License Agreement between the Company and Novartis International Pharmaceutical Ltd., dated September 30, 2015 (this exhibit was previously filed under confidential treatment... (Filed With SEC on November 5, 2020)
Description of Registrants Securities (Filed With SEC on March 10, 2020)
Lease Termination Agreement, dated December 17, 2019, by and between XOMA Corporation and 7th Street Property General Partnership (Filed With SEC on March 10, 2020)
Separation Agreement dated August 31, 2019 between the Company and Dee Datta (Filed With SEC on November 5, 2019)
Amendment No. 3, dated March 31, 2020, to the Common Stock Purchase Agreement, dated December 6, 2017, between XOMA Corporation and Rezolute, Inc. (formerly AntriaBio, Inc.) (Filed With SEC on May 5, 2020)
Collaboration and License Agreement, dated as of March 5, 2020, by and between XOMA (US) LLC and Cadila Healthcare Limited (Filed With SEC on May 5, 2020)
Lease Termination Agreement, dated December 17, 2019, by and between XOMA Corporation and 7th Street Properties II (Filed With SEC on March 10, 2020)
Investment Agreement, dated November 19, 2019 (Filed With SEC on November 20, 2019)
Royalty Purchase Agreement dated September 26, 2019 between XOMA (US) LLC and Palobiofarma, S.L (Filed With SEC on November 5, 2019)
Royalty Purchase Agreement dated April 7, 2019, between XOMA (US) LLC and Aronora, Inc (Filed With SEC on August 6, 2019)
Form of Warrant (March 2019 Warrant) (Filed With SEC on May 6, 2019)
First Amendment, dated March 4, 2019, to the Loan and Security Agreement dated May 7, 2018, between XOMA Corporation, XOMA (US) LLC and XOMA Technology, Ltd. and Silicon Valley... (Filed With SEC on May 6, 2019)
Amendment No. 2, dated January 7, 2019, to the License Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio) (Filed With SEC on March 7, 2019)
Amendment No. 2, dated January 7, 2019, to the Common Stock Purchase Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio) (Filed With SEC on March 7, 2019)